Earnings Feed
Start Free
Home/Filings/4/0001225208-24-001867
4//SEC Filing

SELLERS ROBERT W.A. 4

Accession 0001225208-24-001867

CIK 0001099800other
View on SEC.govCompany Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:44 PM ET

Size

9.0 KB

Accession

0001225208-24-001867

Insider Transaction Report

Form 4
Period: 2024-02-12
Edwards Lifesciences CorpEW
SELLERS ROBERT W.A.
VP, Corporate Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-12$36.75/sh+12,210$448,718→ 25,297.184 total
  • Sale

    Common Stock

    2024-02-12$87.00/sh−12,210$1,062,270→ 13,087.184 total
  • Exercise/Conversion

    Employee Stock Option (Right to Acquire)

    2024-02-12−12,210→ 0 total
    Exercise: $36.75From: 2018-05-11Exp: 2024-05-10→ Common Stock (12,210 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    20,409

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

→
Entity typeother

Related Parties

1
  • filerCIK 0001600739

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:44 PM ET
Size
9.0 KB
View on SEC.gov